News

Gravity's Q3 2024 Financial Report: Insights & Future Plans

Gravity's Q3 2024 Financial Report: Insights & Future Plans

Gravity Co., Ltd. Reports Impressive Q3 2024 Results

Seoul, November 12, 2024 – GRAVITY Co., Ltd. (NASDAQ: GRVY), renowned for developing and publishing captivating online and mobile games, has announced promising financial results for the third quarter ended September 30, 2024. These results, reflecting the company's resilience despite challenges, are prepared in accordance with International Financial Reporting Standards, showcasing the company's strategic efforts in the competitive gaming sector.

Third Quarter 2024 Financial Highlights

In Q3 2024, Gravity recorded total revenues of KRW 128,376 million (approximately US$ 97,629 thousand), marking a 4.4% increase compared to the previous quarter but a 27.1% decrease compared to the same period last year. Operating profit surged by 84.0% quarter-over-quarter to KRW 27,576 million (around US$ 20,971 thousand), although this reflects a decline of 27.3% year-over-year. The profit before income tax expenses reached KRW 28,415 million (US$ 21,609 thousand), soaring by 41.7% from the second quarter, yet down 31.0% from the third quarter of 2023.

Performance Breakdown

The net profit attributable to the parent company for Q3 amounted to KRW 22,385 million (US$ 17,023 thousand), demonstrating a substantial increase of 78.1% from the previous quarter but a decrease of 22.7% year-on-year. This profitability highlights the company's ongoing commitment to delivering engaging games while navigating a complex market landscape.

Revenue Insights from Q3 2024

Gravity's online gaming revenues for the quarter increased to KRW 19,657 million (US$ 14,949 thousand), a modest 1.1% rise quarter-over-quarter and a notable 13.5% increase year-over-year. The driving force behind this revenue increase was the continued success of popular titles such as Ragnarok Landverse in Thailand and Ragnarok Online in China, which significantly contributed to the quarterly growth.

Mobile Gaming Revenue Growth

Mobile game revenues, however, faced a decline year-over-year, totaling KRW 102,524 million (US$ 77,969 thousand), down 34.1% from KRW 155,467 million a year prior. The positive news is that the revenue did increase by 3.5% from the previous quarter. The newly launched game THE RAGNAROK has particularly gained traction in key markets, driving some of this revenue growth.

Cost of Revenue and Operational Expenses

The cost of revenue stood at KRW 76,261 million (US$ 57,996 thousand), reflecting a slight increase of 0.3% from the prior quarter, while there was a significant year-over-year reduction of 35.3%. This decline in costs was primarily attributed to decreasing commissions tied to mobile game services wherein game performance fluctuated.

Operational Expenses Analysis

Operating expenses decreased by 23.2% quarter-over-quarter to KRW 24,539 million (US$ 18,662 thousand), arising mainly from lower advertising spend related to mobile services. However, year-over-year, these expenses increased by 20.3%, driven by marketing campaigns for major releases in South Korea and growing developer costs.

Liquidity Position

In terms of liquidity, as of September 30, 2024, Gravity had a robust cash and short-term financial instruments balance of KRW 513,993 million (US$ 390,887 thousand), solidifying its ongoing operational viability and ability to invest in future projects.

Upcoming Game Releases and Business Direction

Gravity continues to push forward with numerous game launches planned for the upcoming quarters. THE RAGNAROK launched in Korea on September 9, 2024, and its expansion into Southeast Asia is already generating excitement. Furthermore, Ragnarok X: Next Generation debuted in China with preparations for further expansions in Japan, North, Central, and South America, and Europe anticipated in 2025.

Future Plans for Gaming IP

Gravity remains committed to maximizing the potential of its gaming intellectual properties. Projects such as PROJECT ABYSS are in development, further showcasing the company’s potential to innovate and cater to evolving player preferences.

Investor Insights

Gravity has also released its investor presentation, detailing business updates, third-quarter results, and the strategic roadmap ahead. These are designed to keep investors informed and engaged regarding the dynamic changes within the gaming landscape.

About GRAVITY Co., Ltd.

Gravity Co., Ltd. is recognized as a leading developer and publisher in the global gaming industry. Notably, its flagship title, Ragnarok Online, has captivated audiences across multiple regions, including Japan and Taiwan, and is available in 91 markets worldwide. For further information, please refer to their investor relations section.

Frequently Asked Questions

What were Gravity's total revenues for Q3 2024?

Gravity reported total revenues of KRW 128,376 million (US$ 97,629 thousand) for the third quarter of 2024.

How did Gravity's operating profit change from Q2 to Q3 2024?

The company experienced a remarkable quarter-over-quarter increase of 84.0% in operating profit, reaching KRW 27,576 million (approximately US$ 20,971 thousand).

What are the key drivers for the increase in online game revenues?

The increase can be attributed to growing revenues from popular titles such as Ragnarok Landverse in Thailand and Ragnarok Online in China.

What new games is Gravity planning to release?

Gravity has several upcoming game launches, including Ragnarok X: Next Generation and PROJECT ABYSS.

How does Gravity ensure liquidity for future investments?

As of September 30, 2024, the company maintained a balance of KRW 513,993 million (US$ 390,887 thousand) in cash and cash equivalents, ensuring adequate liquidity for future projects.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

BioCryst Pharmaceuticals Reports Positive Outcomes for ORLADEYO

Updated Category News Views 62

BioCryst Pharmaceuticals Highlights ORLADEYO's Impact BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has unveiled a compelling study that underscores how ORLADEYO (berotralstat) significantly lowers healthcare resource utilization (HRU) for patients battling hereditary angioedema (HAE). This innovative oral treatment has garnered attention due to its remarkable findings,...

Continue Reading
Man Group PLC Discloses Interest in Spectris plc Shares

Updated Category News Views 174

Understanding Man Group PLC's Position Disclosure Man Group PLC is making headlines as it officially discloses its holdings in Spectris plc. This disclosure is known as FORM 8.3 and is a crucial document under Rule 8.3 of the Takeover Code. It indicates the shareholding interests of Man Group in Spectris, representing a significant percentage of the company's relevant...

Continue Reading
Centessa Pharmaceuticals Seeks $225 Million Through Public Offering

Updated Category News Views 91

Centessa Pharmaceuticals Launches Major $225 Million Offering Centessa Pharmaceuticals plc (NASDAQ: CNTA), an innovative clinical-stage pharmaceutical company, has announced an ambitious public offering with the goal of raising around $225 million. This offering features 15,254,237 American Depositary Shares (ADSs), each representing one ordinary share, priced at $14.75...

Continue Reading
Unveiling Software Giants: Microsoft and Its Rivals in 2024

Updated Category News Views 350

Understanding the Competitive Landscape of Software Giants In the dynamic world of software, staying informed about leading companies is vital for investors and analysts alike. This article focuses on Microsoft (NASDAQ: MSFT) and its primary competitors, aiming to deliver a thorough analysis of financial statistics, market standings, and opportunities for growth within...

Continue Reading
Harris Leads Trump by 3 Points in Key Election Polls

Updated Category News Views 105

Election Polls Show Harris's Slim Lead Over Trump In the battleground of the upcoming U.S. presidential election, Democratic Vice President Kamala Harris has established a slender lead over Republican contender Donald Trump, according to the latest polling data. Recent surveys indicate that Harris is ahead by a margin of 3 points, with her support reaching 45% compared to...

Continue Reading